tranexamic acid has been researched along with ADPKD in 5 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
Excerpt | Relevance | Reference |
---|---|---|
"In this retrospective study we aimed to compare the effect of tranexamic acid (TXA) vs etamsylate, two hemostatic agents, on hematuria duration in autosomal dominant polycystic kidney disease (ADPKD) patients with persistent gross hematuria." | 7.85 | Treatment of Persistent Gross Hematuria with Tranexamic Acid in Autosomal Dominant Polycystic Kidney Disease. ( Bian, R; Chen, D; Dai, B; Fu, L; Hu, X; Li, L; Ma, Y; Mei, CL; Sun, L; Wu, M; Wüthrich, RP; Xing, X; Yao, Q; Zhou, J; Zhou, M, 2017) |
"In this retrospective study we aimed to compare the effect of tranexamic acid (TXA) vs etamsylate, two hemostatic agents, on hematuria duration in autosomal dominant polycystic kidney disease (ADPKD) patients with persistent gross hematuria." | 3.85 | Treatment of Persistent Gross Hematuria with Tranexamic Acid in Autosomal Dominant Polycystic Kidney Disease. ( Bian, R; Chen, D; Dai, B; Fu, L; Hu, X; Li, L; Ma, Y; Mei, CL; Sun, L; Wu, M; Wüthrich, RP; Xing, X; Yao, Q; Zhou, J; Zhou, M, 2017) |
"The aim of this study was to evaluate prospectively the response to tranexamic acid in a group of 8 patients with ADPKD and gross haematuria unresponsive to conventional treatment." | 3.78 | Medical therapy with tranexamic acid in autosomal dominant polycystic kidney disease patients with severe haematuria. ( Aguilar, A; Cuesta, E; Peces, C; Peces, R; Selgas, R; Vega, C, 2012) |
"Oral tranexamic acid was trialed with stabilization of the hemoglobin." | 1.91 | Life-Threatening Retroperitoneal Hemorrhage Following Cyst Rupture in Autosomal Dominant Polycystic Kidney Disease (ADPKD): A Case Report. ( Chebib, FT; Chedid, M; Duriseti, P; Hanna, C; Potrezke, TA; Radhakrishnan, Y, 2023) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Duriseti, P | 1 |
Radhakrishnan, Y | 1 |
Chedid, M | 1 |
Hanna, C | 1 |
Potrezke, TA | 1 |
Chebib, FT | 1 |
Yao, Q | 1 |
Wu, M | 1 |
Zhou, J | 1 |
Zhou, M | 1 |
Chen, D | 1 |
Fu, L | 1 |
Bian, R | 1 |
Xing, X | 1 |
Sun, L | 1 |
Hu, X | 1 |
Li, L | 1 |
Dai, B | 1 |
Wüthrich, RP | 1 |
Ma, Y | 1 |
Mei, CL | 1 |
Peces, R | 1 |
Aguilar, A | 1 |
Vega, C | 1 |
Cuesta, E | 1 |
Peces, C | 1 |
Selgas, R | 1 |
Hui, AC | 1 |
Wong, TY | 1 |
Chow, KM | 1 |
Szeto, CC | 1 |
1 review available for tranexamic acid and ADPKD
Article | Year |
---|---|
Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. BET 1: tranexamic acid in life-threatening haematuria.
Topics: Antifibrinolytic Agents; Evidence-Based Emergency Medicine; Hematuria; Humans; Polycystic Kidney, Au | 2015 |
4 other studies available for tranexamic acid and ADPKD
Article | Year |
---|---|
Life-Threatening Retroperitoneal Hemorrhage Following Cyst Rupture in Autosomal Dominant Polycystic Kidney Disease (ADPKD): A Case Report.
Topics: Cysts; Hemorrhage; Humans; Kidney; Male; Middle Aged; Polycystic Kidney, Autosomal Dominant; Rupture | 2023 |
Treatment of Persistent Gross Hematuria with Tranexamic Acid in Autosomal Dominant Polycystic Kidney Disease.
Topics: Adult; Ethamsylate; Female; Hematuria; Hemostatics; Humans; Male; Middle Aged; Polycystic Kidney, Au | 2017 |
Medical therapy with tranexamic acid in autosomal dominant polycystic kidney disease patients with severe haematuria.
Topics: Adult; Antifibrinolytic Agents; Female; Hematuria; Humans; Male; Middle Aged; Polycystic Kidney, Aut | 2012 |
Multifocal myoclonus secondary to tranexamic acid.
Topics: Antifibrinolytic Agents; Catheters, Indwelling; Hemorrhage; Humans; Male; Middle Aged; Myoclonus; Pe | 2003 |